OTC drug makers struggling to set normal market price

Published: 2008-08-12 06:16:00

Updated: 2008-08-12 06:16:00

Despite incessant price hike of some renowned OTC products in recent months, some of OTC makers have endeavored to firmly establish their normal prices amid cut-throat competition, according to pharmaceutical sources.

OTC pharmaceutical firms are moving to increase the sales of summer-season d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK